Table 2.
Drug | Dosing | Therapeutic drug monitoring |
References | ||
---|---|---|---|---|---|
Neonates (0–30 days) |
Infants (31 days–2 years) |
Children (2 years–17 years) |
|||
Polyenes | |||||
Amphotericin B | 0.6−1 mg/kg IV q24h | 0.6−1 mg/kg IV q24h | 0.6−1 mg/kg IV q24h | No | [23-27, 167] |
ABLC | 2.5−5 mg/kg q24h | Unknown | 5 mg/kg IV q24h | No | [39, 50, 51, 183] |
ABCD | unknown | Unknown | Unknown | No | |
L-AmB | 3-5 mg/kg q24h | 3–5 mg/kg IV q24h | 3–6 mg/kg IV q24h | No | [47-49, 193] |
Triazoles | |||||
Fluconazole | Loading dose 25 mg/kg 12 mg/kg q24h (3–6 mg/kg twice weekly for prophylaxis) |
12 mg/kg IV q24h (3 mg/kg IV q24h for prophylaxis) |
6-12 mg/kg IV or PO q24h (3 mg/kg q24h for prophylaxis) |
No | [64-66] |
Itraconazole | unknown | Unknown | 2.5–5 mg/kg PO q12h (2.5 mg/kg PO q24h for prophylaxis) |
Trough >0.5 mg/Lc | [57, 74-76, 78] |
Voriconazole | unknown | Unknown | 7–9 mg/kg IV q12ha 200 mg PO q12h (2.5 mg/kg PO q12h for prophylaxis) |
Trough 1.0-5.5 mg/L | [62, 91, 99, 190] |
Posaconazole | unknown | Unknown | 200–400 mg PO q6–12 hb | Prophylaxis : trough>0.5 mg/Lc Treatment : trough >1 mg/Lc |
[168] |
Ravuconazole
Albaconazole Isavuconazole |
unknown | Unknown | unknown | unknown | |
Echinocandins | [148-150, 153, 155] |
||||
Caspofungin | 25 mg/m2 IV q24h | 50 mg/m2 IV q24h | Load with 70 mg/m2 IV once, then 50 mg/m2 IV q24h |
No | |
Micafungin | 10 mg/kg IV q24h | 3–4 mg/kg IV q24h | 2–4 mg/kg IV q24h (1 mg/kg IV q24h for prophylaxis) |
No | [2, 125, 135, 138, 141] |
Anidulafungin | Load with 3 mg/kg IV once, then 1.5 mg/kg IV q24h |
Load with 3 mg/kg IV once, then 1.5 mg/kg IV q24h |
Load with 3 mg/kg IV once, then 1.5 mg/kg IV q24h |
No | [105, 163, 164] |
Aminocandin | unknown | unknown | unknown | unknown | |
Nucleoside analogs | |||||
5-Flucytosine | unknown | unknown | unknown | Cmax : 20−50 mg/Lc | [120, 181] |
ABCD=amphotericin B colloidal dispersion; ABLC=amphotericin B lipid complex; AUC=area under the concentration-time curve; AUC:MIC=AUC over minimal inhibitory concentration ratio; Cmax= maximal concentration; div=divided dose; EMA=European Medicines Agency; FDA=Food and Drug Administration; IV=intravenous; L-AmB=liposomal amphotericin B; MIC=minimal inhibitory concentration; PD=pharmacodynamics; PO=oral; NR=not reported; q=every; T>MIC=time concentrations are over the MIC.
Dosing for <12 years old. For children ≥ 12 years old, adult dosing is recommended.
Dosing unknown for children <12 years of age.
Target concentrations in adults.